An updated review of the optimal lithium dosage regimen for renal protection

Canadian Journal of Psychiatry

Volumn 58, Issue 10, 2013, Pages 595-600

  Carter, Lorie ^a   Zolezzi, Monica ^b   Lewczyk, Andrea ^c  

^a Health Sciences Centre St John's   (Canada)

^b ALBERTA HEALTH SERVICES   (Canada)

^c ALBERTA HOSPITAL EDMONTON   (Canada)

Author keywords

Dose response relation; Drug administration schedule; Lithium; Polyuria

Indexed keywords

CREATININE; LITHIUM;

BIPOLAR DISORDER; CHRONIC KIDNEY DISEASE; COMORBIDITY; CREATININE BLOOD LEVEL; DIETARY COMPLIANCE; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; FLUID INTAKE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BIOPSY; KIDNEY CONCENTRATING CAPACITY; KIDNEY FUNCTION; KIDNEY TUBULE FUNCTION; OPTIMAL DRUG DOSE; POLYDIPSIA; POLYURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL PROTECTION; RENAL REPLACEMENT THERAPY; REVIEW; SUSTAINED DRUG RELEASE; SYSTEMATIC REVIEW; TREATMENT DURATION; TREMOR; URINARY FREQUENCY; URINE VOLUME;

EID: 84885450496     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371305801009     Document Type: Review

References (37)

1. Yatham LN, Kennedy SH, Schaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009;11(3):225-255.
2. Ferrier N, Ferrie L, Macritchie K. Old drug, new data: revisiting lithium therapy. Adv Psychiatr Treat. 2006;12:256-264.
3. McKnight RF, Adida M, Budge K, et al. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379(9817):721-728.
4. Oliveira JL, Silva GB Jr, Abreu KL, et al. Lithium nephrotoxicity. Rev Assoc Med Bras. 2010;56(5):600-606.
5. Perry PJ, Dunner FJ, Hahn RL, et al. Lithium kinetics in single daily dosing. Acta Psychiat Scand. 1981;64(4):281-294. (Pubitemid 12242337)
6. Goodwin GM, Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: revised second edition - recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2009;23(4):346-388.
7. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159(4 Suppl):1-50.
8. Amdisen A. Clinical and serum-level monitoring in lithium therapy and lithium intoxication. J Anal Toxicol. 1978;2:193-202. (Pubitemid 9060251)
9. Ljubicic D, Letica-Crepulja M, Vitezic D, et al. Lithium treatments: single and multiple daily dosing. Can J Psychiatry. 2008;53(5):323-331. (Pubitemid 351838512)
10. Malhi GS, Adams D, Lampe L, et al. Clinical practice recommendations for bipolar disorder. Acta Psychiatr Scand. 2009;439:27-46.
11. Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry. 2009;10(2):85-116.
12. Licht RW, Vestergaard P, Kessing LV, et al. Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr Scand. 2003;419:1-22. (Pubitemid 37297197)
13. Movig K, Baumgarten R, Leufkens H, et al. Risk factors for the development of lithium-induced polyuria. Br J Psychiatry. 2003;182:319-323. (Pubitemid 36408283)
14. Boton R, Gaviria M, Batlle D. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis. 1987;10(5):329-345. (Pubitemid 17161686)
15. Gitlin M. Lithium and the kidney: an updated review. Drug Saf. 1999;20(3):231-243.
16. Jorgensen F, Larsen S, Spanager B, et al. Kidney function and quantitative histological changes in patients on long-term lithium therapy. Acta Psychiat Scand. 1984;70:455-462. (Pubitemid 15182220)
17. Schou M, Amdisen A, Thomsen K, et al. Lithium treatment regimen and renal water handling: the significance of dosage patterns and tablet type examined through comparison of results from two clinics with different treatment regimens. Psychopharmacology (Berl). 1982;77(4):387-390. (Pubitemid 12061708)
18. Plenge P, Mellerup ET, Bolwig TG, et al. Lithium treatment: does the kidney prefer one daily dose instead of two? Acta Psychiatr Scand. 1982;66(2):121-128. (Pubitemid 12065652)
19. Bowen RC, Grof P, Grof E. Less frequent lithium administration and lower urine volume. Am J Psychiatry. 1991;148(2):189-192.
20. Kusalic M, Engelsmann F. Renal reactions to changes of lithium dosage. Neuropsychobiology. 1996;34(3):113-116. (Pubitemid 26355754)
21. Hetmar O, Bolwig TG, Brun C, et al. Lithium: long-term effects on the kidney. Acta Psychiatr Scand. 1986;73(5):574-581.
22. Hetmar O, Clemmesen L, Ladefoged J, et al. Lithium: long-term effects on the kidney. III. Prospective study. Acta Psychiatr Scand. 1987;75(3):251-258. (Pubitemid 17041501)
23. Hetmar O, Povlsen UJ, Ladefoged J, et al. Lithium: long-term effects on the kidney. A prospective follow-up study ten years after kidney biopsy. Br J Psychiatry. 1991;158:53-58.
24. Abraham G, Delva N, Waldron J, et al. Lithium treatment: a comparison of once and twice-daily dosing. Acta Psychiatr Scand. 1992;85(1):65-69.
25. Abraham G, Waldron JJ, Lawson JS. Are the renal effects of lithium modified by frequency of administration? Acta Psychiatr Scand. 1995;92(2):115-118.
26. Greil W, Bauer J, Breit J, et al. Single daily dose schedule in lithium long-term treatment: effects on pharmacokinetics and on renal and cardiac functions. Pharmacopsychiatry. 1985;18:106-107. (Pubitemid 15137663)
27. Muir A, Davidson R, Silverstone T, et al. Two regimens of lithium prophylaxis and renal function. Acta Psychiatr Scand. 1989;80(6):579-583. (Pubitemid 20046943)
28. O'Donovan C, Hawkes J, Bowen R. Effect of lithium dosing schedule on urinary output. Acta Psychiatr Scand. 1993;87(2):92-95. (Pubitemid 23062196)
29. Singh LK, Nizamie SH, Akhtar S, et al. Improving tolerability of lithium with a once-daily dosing schedule. Am J Ther. 2011;18:288-291.
30. Jensen HV, Olafsson K, Bille A, et al. Lithium every second day: a new treatment regimen? Lithium. 1990;1:55-58. (Pubitemid 20375421)
31. Jensen HV, Plenge P, Mellerup ET, et al. Lithium prophylaxis of manic-depressive disorder: daily lithium dosing schedule versus every second day. Acta Psychiatr Scand. 1995;92(1):69-74.
32. Jensen HV, Davidsen K, Toftegaard L, et al. Double-blind comparison of the adverse effect profiles of daily versus alternate-day dosing schedules in lithium maintenance treatment of manic-depressive disorder. J Affect Disord. 1996;36:89-93. (Pubitemid 26040156)
33. Plenge P, Amin M, Agarwal AK, et al. Prophylactic efficacy of lithium administered every second day: a WHO multicentre study. Bipolar Disord. 1999;1(2):109-116.
34. Müller-Oerlinghausen B, Bauer M, Grof P. Commentary on a recent review of lithium toxicity: what are its implications for clinical practice? BMC Med. 2012;10:132.
35. Bocchetta A, Ardau R, Carta P, et al. Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study. BMC Med. 2013;11:33.
36. Bendz H, Schön S, Attman P, et al. Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int. 2010;77:219-224.
37. Hetmar O, Brun C, Clemmesen L, et al. Lithium: long-term effects on the kidney. II. Structural changes. J Psychiatr Res. 1987;21(3):279-288.